Thys J P, Vanderhoeft P, Herchuelz A, Bergmann P, Yourassowsky E
Infectious Diseases Clinic, Cliniques Universitaires de Bruxelles, Belgium.
Chest. 1988 Mar;93(3):530-2. doi: 10.1378/chest.93.3.530.
The concentrations of gentamicin, netilmicin, and amikacin were determined after one single intravenous injection in uninfected pleural fluid after thoracotomy and in purulent pleural empyemas. The mean peak concentrations in the pleural fluid after the injection of gentamicin (1.5 mg/kg), netilmicin (2.0 mg/kg), and amikacin (7.5 mg/kg) were 2.9 +/- 0.3 mg/L, 3.7 +/- 0.8 mg/L, and 11.0 +/- 3.1 mg/L, respectively. The pleural penetration of the drugs was very high (from 80.0 to 99.1 percent). By contrast, gentamicin and netilmicin were not detectable in empyema pus; in this exudate the mean peak level of amikacin was 5.7 +/- 2.2 mg/L, with the penetration of this drug being 31.0 percent. The concentrations of parenterally administered aminoglycosides are substantially lower in empyema pus than in sterile pleural fluid. The possibility of poor pleural penetration of some aminoglycosides, as well as the presence of local conditions in pleural empyema unfavorable to the bioactivity of these drugs, must be kept in mind when treating pleural infections.
在开胸术后未感染的胸腔积液以及脓性胸腔积脓中,单次静脉注射后测定了庆大霉素、奈替米星和阿米卡星的浓度。注射庆大霉素(1.5mg/kg)、奈替米星(2.0mg/kg)和阿米卡星(7.5mg/kg)后,胸腔积液中的平均峰值浓度分别为2.9±0.3mg/L、3.7±0.8mg/L和11.0±3.1mg/L。药物的胸腔穿透率非常高(80.0%至99.1%)。相比之下,在积脓中未检测到庆大霉素和奈替米星;在这种渗出液中,阿米卡星的平均峰值水平为5.7±2.2mg/L,该药物的穿透率为31.0%。胸腔积脓中经胃肠外给药的氨基糖苷类药物浓度明显低于无菌胸腔积液。在治疗胸腔感染时,必须牢记某些氨基糖苷类药物胸腔穿透性差的可能性,以及胸腔积脓中不利于这些药物生物活性的局部情况。